![A phase 1b randomised controlled trial of a glucagon-like peptide-1 and glucagon receptor dual agonist IBI362 (LY3305677) in Chinese patients with type 2 diabetes | Nature Communications A phase 1b randomised controlled trial of a glucagon-like peptide-1 and glucagon receptor dual agonist IBI362 (LY3305677) in Chinese patients with type 2 diabetes | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-022-31328-x/MediaObjects/41467_2022_31328_Fig1_HTML.png)
A phase 1b randomised controlled trial of a glucagon-like peptide-1 and glucagon receptor dual agonist IBI362 (LY3305677) in Chinese patients with type 2 diabetes | Nature Communications
![Testing a 3-in-1 Machine || Laser Engraver/Cutter, 3D Printer, CNC Machine || Snapmaker 2.0 - YouTube Testing a 3-in-1 Machine || Laser Engraver/Cutter, 3D Printer, CNC Machine || Snapmaker 2.0 - YouTube](https://i.ytimg.com/vi/BSWcrzghlCs/maxresdefault.jpg)
Testing a 3-in-1 Machine || Laser Engraver/Cutter, 3D Printer, CNC Machine || Snapmaker 2.0 - YouTube
![Universal pH Test Strips - pH Tester Strips Kit with e-Book - 150 Quick and Easy pH Testing Strips - Ultimate pH Balance Test Strips Kit - 150 Strips by JNW Direct: Universal pH Test Strips - pH Tester Strips Kit with e-Book - 150 Quick and Easy pH Testing Strips - Ultimate pH Balance Test Strips Kit - 150 Strips by JNW Direct:](https://m.media-amazon.com/images/I/81lUji6gJnL._SX342_.jpg)
Universal pH Test Strips - pH Tester Strips Kit with e-Book - 150 Quick and Easy pH Testing Strips - Ultimate pH Balance Test Strips Kit - 150 Strips by JNW Direct:
![Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): results from two replicate double-blind, randomised controlled phase 3 trials - The Lancet Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): results from two replicate double-blind, randomised controlled phase 3 trials - The Lancet](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/1b0fb609-66bf-42ec-8a08-d46c6b8db9af/gr1.jpg)
Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): results from two replicate double-blind, randomised controlled phase 3 trials - The Lancet
![Hyperelastic Material Models and Curve Fitting | by WELSIM - Engineering Simulation Software | Medium Hyperelastic Material Models and Curve Fitting | by WELSIM - Engineering Simulation Software | Medium](https://miro.medium.com/max/1400/1*qGZqEjC55Omu0OhBi9fOgQ.png)
Hyperelastic Material Models and Curve Fitting | by WELSIM - Engineering Simulation Software | Medium
![TNF-α synergises with IFN-γ to induce caspase-8-JAK1/2-STAT1-dependent death of intestinal epithelial cells | Cell Death & Disease TNF-α synergises with IFN-γ to induce caspase-8-JAK1/2-STAT1-dependent death of intestinal epithelial cells | Cell Death & Disease](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41419-021-04151-3/MediaObjects/41419_2021_4151_Fig1_HTML.png)
TNF-α synergises with IFN-γ to induce caspase-8-JAK1/2-STAT1-dependent death of intestinal epithelial cells | Cell Death & Disease
![Improving reproducibility in animal research by splitting the study population into several 'mini-experiments' | Scientific Reports Improving reproducibility in animal research by splitting the study population into several 'mini-experiments' | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-020-73503-4/MediaObjects/41598_2020_73503_Fig1_HTML.png)
Improving reproducibility in animal research by splitting the study population into several 'mini-experiments' | Scientific Reports
![Novel fatty chain-modified GLP-1R G-protein biased agonist exerts prolonged anti-diabetic effects through targeting receptor binding sites - RSC Advances (RSC Publishing) DOI:10.1039/C9RA10593J Novel fatty chain-modified GLP-1R G-protein biased agonist exerts prolonged anti-diabetic effects through targeting receptor binding sites - RSC Advances (RSC Publishing) DOI:10.1039/C9RA10593J](https://pubs.rsc.org/image/article/2020/RA/c9ra10593j/c9ra10593j-f3_hi-res.gif)
Novel fatty chain-modified GLP-1R G-protein biased agonist exerts prolonged anti-diabetic effects through targeting receptor binding sites - RSC Advances (RSC Publishing) DOI:10.1039/C9RA10593J
![Safety and Efficacy of Glucagon-Like Peptide-1 Receptor Agonists in Children and Adolescents with Obesity: A Meta-Analysis - The Journal of Pediatrics Safety and Efficacy of Glucagon-Like Peptide-1 Receptor Agonists in Children and Adolescents with Obesity: A Meta-Analysis - The Journal of Pediatrics](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/825611c0-96ef-4a30-891a-c255229b6908/gr1.jpg)